Every 10-Q that Middlesex Water Co (MSEX) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MSEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MSEX filings page.
Middlesex Water Company reported higher operating revenues and earnings for the quarter ended June 30, 2026, with operating revenues of $56,357 thousand and net income of $14,772 thousand, compared with $49,323 thousand and $10,778 thousand a year earlier. Diluted EPS was $0.79, and six‑month diluted EPS was $1.36 on revenues of $105,071 thousand.
Growth reflected a New Jersey Board of Public Utilities approval of a $14.5 million base rate increase for Middlesex and Pinelands effective February 23, 2026, along with higher consumption and customer growth at Tidewater. Regulated operations provided most of the improvement. The company invested $53,468 thousand in capital expenditures in the first half and plans about $126 million in 2026 spending within a $506 million 2026‑2028 program focused on PFAS treatment, lead service line replacement and system upgrades. Funding sources include State Revolving Fund loans, a new $25.0 million CoBank term loan, expanded credit lines totaling $180.0 million, and at‑the‑market equity issuance that generated $14.0 million in net proceeds year‑to‑date. Through June 30, 2026, the company also received $8.1 million from PFAS MDL settlements that are expected to be shared with customers.
Middlesex Water Company reported stronger results for the quarter ended March 31, 2026. Operating revenues rose to $48.7 million from $44.3 million, and earnings applicable to common stock increased to $10.6 million, or $0.57 per share, compared with $0.53 a year earlier.
Regulated operations drove most of the growth, helped by a $14.5 million annual base rate increase approved in New Jersey effective February 23, 2026, along with higher usage and customer growth in Delaware. The company received $6.0 million from PFAS multi-district litigation settlements, with proceeds being shared with customers through bill credits and refunds. Capital spending remained heavy at $20.6 million in the quarter, mainly for water infrastructure and PFAS treatment projects, funded by a mix of operating cash flow, state revolving fund loans, bank credit lines and an at-the-market equity program.
Middlesex Water Company reported Q3 2025 results with operating revenue of $54.091 million versus $55.100 million a year ago, and diluted EPS of $0.77 versus $0.80. Net income was $13.958 million (vs. $14.319 million). Operating income held at $17.703 million (vs. $17.501 million) as lower consumption from unfavorable weather offset rate mechanisms and growth.
For the first nine months, revenue was $147.715 million (vs. $144.770 million) and diluted EPS was $1.90 (vs. $1.98). Operating cash flow increased to $44.134 million (vs. $37.335 million), supporting a capital program with year‑to‑date capex of $71.642 million and the $4.6 million Ocean View, DE asset acquisition. The company issued 316,786 shares in Q3 under its ATM, generating $16.7 million in net proceeds and $20.3 million year‑to‑date, with $89.4 million of capacity remaining.
Regulatory updates included a $5.5 million annual revenue increase at Tidewater effective July 3, 2025, ongoing NJ DSIC filings (an additional $0.9 million expected), and NJ PWAC recovery of $0.5 million. The company recorded $0.4 million in Q3 PFAS settlement proceeds and received $0.7 million more in October, intended for customer benefit pending approvals.